Switching treatment from parenteral anticoagulants to apixaban (and vice versa) can be done at the next scheduled dose.
These medicinal products should not be administered simultaneously.
When converting patients from VKA therapy to apixaban, discontinue warfarin or other VKA therapy and start apixaban when the international normalised ratio (INR) is <2.0 (Figure 5).
When converting patients from apixaban to VKA therapy, continue administration of apixaban for at least 2 days after beginning VKA therapy. After 2 days of
This Prescriber Guide is not a substitute for the apixaban Summary of Product Characteristics (SmPC). Please consult the SmPC for full prescribing information.